Proliferative Diabetic Retinopathy Market - Global Outlook and Forecast 2021-2027

Code: RW00014556152
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Proliferative Diabetic Retinopathy in Global, including the following market information:
Global Proliferative Diabetic Retinopathy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Proliferative Diabetic Retinopathy market was valued at 454.7 million in 2020 and is projected to reach US$ 556.3 million by 2027, at a CAGR of 5.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Proliferative Diabetic Retinopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Proliferative Diabetic Retinopathy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Proliferative Diabetic Retinopathy Market Segment Percentages, By Type, 2020 (%)
Anti-VEGF Agents
Corticosteroids

China Proliferative Diabetic Retinopathy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Proliferative Diabetic Retinopathy Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Proliferative Diabetic Retinopathy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Proliferative Diabetic Retinopathy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Proliferative Diabetic Retinopathy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Proliferative Diabetic Retinopathy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Intas Pharmaceuticals
Santen Pharmaceutical
Bausch Health
Allergan Plc
Regeneron Pharmaceuticals
Merck KGaA
Cipla
Genentech, Inc. (Roche Holdings)
Novartis
Pfizer

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Proliferative Diabetic Retinopathy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Proliferative Diabetic Retinopathy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Proliferative Diabetic Retinopathy Overall Market Size
2.1 Global Proliferative Diabetic Retinopathy Market Size: 2021 VS 2027
2.2 Global Proliferative Diabetic Retinopathy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Proliferative Diabetic Retinopathy Players in Global Market
3.2 Top Global Proliferative Diabetic Retinopathy Companies Ranked by Revenue
3.3 Global Proliferative Diabetic Retinopathy Revenue by Companies
3.4 Top 3 and Top 5 Proliferative Diabetic Retinopathy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Proliferative Diabetic Retinopathy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Proliferative Diabetic Retinopathy Players in Global Market
3.6.1 List of Global Tier 1 Proliferative Diabetic Retinopathy Companies
3.6.2 List of Global Tier 2 and Tier 3 Proliferative Diabetic Retinopathy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Proliferative Diabetic Retinopathy Market Size Markets, 2021 & 2027
4.1.2 Anti-VEGF Agents
4.1.3 Corticosteroids
4.2 By Type - Global Proliferative Diabetic Retinopathy Revenue & Forecasts
4.2.1 By Type - Global Proliferative Diabetic Retinopathy Revenue, 2016-2021
4.2.2 By Type - Global Proliferative Diabetic Retinopathy Revenue, 2022-2027
4.2.3 By Type - Global Proliferative Diabetic Retinopathy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Proliferative Diabetic Retinopathy Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Proliferative Diabetic Retinopathy Revenue & Forecasts
5.2.1 By Application - Global Proliferative Diabetic Retinopathy Revenue, 2016-2021
5.2.2 By Application - Global Proliferative Diabetic Retinopathy Revenue, 2022-2027
5.2.3 By Application - Global Proliferative Diabetic Retinopathy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Proliferative Diabetic Retinopathy Market Size, 2021 & 2027
6.2 By Region - Global Proliferative Diabetic Retinopathy Revenue & Forecasts
6.2.1 By Region - Global Proliferative Diabetic Retinopathy Revenue, 2016-2021
6.2.2 By Region - Global Proliferative Diabetic Retinopathy Revenue, 2022-2027
6.2.3 By Region - Global Proliferative Diabetic Retinopathy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Proliferative Diabetic Retinopathy Revenue, 2016-2027
6.3.2 US Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.3.3 Canada Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.3.4 Mexico Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Proliferative Diabetic Retinopathy Revenue, 2016-2027
6.4.2 Germany Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.3 France Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.4 U.K. Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.5 Italy Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.6 Russia Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.7 Nordic Countries Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.4.8 Benelux Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Proliferative Diabetic Retinopathy Revenue, 2016-2027
6.5.2 China Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.5.3 Japan Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.5.4 South Korea Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.5.5 Southeast Asia Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.5.6 India Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Proliferative Diabetic Retinopathy Revenue, 2016-2027
6.6.2 Brazil Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.6.3 Argentina Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Proliferative Diabetic Retinopathy Revenue, 2016-2027
6.7.2 Turkey Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.7.3 Israel Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.7.4 Saudi Arabia Proliferative Diabetic Retinopathy Market Size, 2016-2027
6.7.5 UAE Proliferative Diabetic Retinopathy Market Size, 2016-2027
7 Players Profiles
7.1 Intas Pharmaceuticals
7.1.1 Intas Pharmaceuticals Corporate Summary
7.1.2 Intas Pharmaceuticals Business Overview
7.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Major Product Offerings
7.1.4 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.1.5 Intas Pharmaceuticals Key News
7.2 Santen Pharmaceutical
7.2.1 Santen Pharmaceutical Corporate Summary
7.2.2 Santen Pharmaceutical Business Overview
7.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Major Product Offerings
7.2.4 Santen Pharmaceutical Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.2.5 Santen Pharmaceutical Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Proliferative Diabetic Retinopathy Major Product Offerings
7.3.4 Bausch Health Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.3.5 Bausch Health Key News
7.4 Allergan Plc
7.4.1 Allergan Plc Corporate Summary
7.4.2 Allergan Plc Business Overview
7.4.3 Allergan Plc Proliferative Diabetic Retinopathy Major Product Offerings
7.4.4 Allergan Plc Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.4.5 Allergan Plc Key News
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporate Summary
7.5.2 Regeneron Pharmaceuticals Business Overview
7.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Major Product Offerings
7.5.4 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.5.5 Regeneron Pharmaceuticals Key News
7.6 Merck KGaA
7.6.1 Merck KGaA Corporate Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Proliferative Diabetic Retinopathy Major Product Offerings
7.6.4 Merck KGaA Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.6.5 Merck KGaA Key News
7.7 Cipla
7.7.1 Cipla Corporate Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Proliferative Diabetic Retinopathy Major Product Offerings
7.4.4 Cipla Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.7.5 Cipla Key News
7.8 Genentech, Inc. (Roche Holdings)
7.8.1 Genentech, Inc. (Roche Holdings) Corporate Summary
7.8.2 Genentech, Inc. (Roche Holdings) Business Overview
7.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Major Product Offerings
7.8.4 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.8.5 Genentech, Inc. (Roche Holdings) Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Proliferative Diabetic Retinopathy Major Product Offerings
7.9.4 Novartis Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.9.5 Novartis Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Proliferative Diabetic Retinopathy Major Product Offerings
7.10.4 Pfizer Proliferative Diabetic Retinopathy Revenue in Global (2016-2021)
7.10.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Proliferative Diabetic Retinopathy Market Opportunities & Trends in Global Market
Table 2. Proliferative Diabetic Retinopathy Market Drivers in Global Market
Table 3. Proliferative Diabetic Retinopathy Market Restraints in Global Market
Table 4. Key Players of Proliferative Diabetic Retinopathy in Global Market
Table 5. Top Proliferative Diabetic Retinopathy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Proliferative Diabetic Retinopathy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Proliferative Diabetic Retinopathy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Proliferative Diabetic Retinopathy Product Type
Table 9. List of Global Tier 1 Proliferative Diabetic Retinopathy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Proliferative Diabetic Retinopathy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE